New Oriental Education & Technology Group (NYSE:EDU – Free Report) had its price objective raised by Morgan Stanley from $85.00 to $95.00 in a research report released on Thursday morning, Benzinga reports. The firm currently has an overweight rating on the stock. Separately, StockNews.com cut New Oriental Education & Technology Group from a buy rating […]
New Oriental Education & Technology Group (NYSE:EDU – Free Report) had its target price raised by Morgan Stanley from $85.00 to $95.00 in a research note released on Thursday, Benzinga reports. They currently have an overweight rating on the stock. Separately, StockNews.com downgraded shares of New Oriental Education & Technology Group from a buy rating […]
Investment Analysts’ price target changes for Thursday, March 28th: Akebia Therapeutics (NASDAQ:AKBA) had its price target raised by HC Wainwright from $5.00 to $6.00. The firm currently has a buy rating on the stock. Ally Financial (NYSE:ALLY) had its target price increased by Evercore ISI from $41.00 to $43.00. Evercore ISI currently has an in-line […]
Investment Analysts’ price target changes for Thursday, March 28th: Akebia Therapeutics (NASDAQ:AKBA) had its price target raised by HC Wainwright from $5.00 to $6.00. The firm currently has a buy rating on the stock. Ally Financial (NYSE:ALLY) had its target price increased by Evercore ISI from $41.00 to $43.00. Evercore ISI currently has an in-line […]
Investment Analysts’ price target changes for Thursday, March 28th: Akebia Therapeutics (NASDAQ:AKBA) had its price target raised by HC Wainwright from $5.00 to $6.00. The firm currently has a buy rating on the stock. Ally Financial (NYSE:ALLY) had its target price increased by Evercore ISI from $41.00 to $43.00. Evercore ISI currently has an in-line […]